Professional Supplements for Wise Athletes (click to see the huge "always on" discount)

• Board certified in internal medicine and obesity medicine, with a long focus on immunometabolism.
• Her book, The Architecture of Enough: Hunger, GLP-1, and the Immune Metabolic System, is available on Amazon (paperback: https://www.amazon.com/Architecture-Enough-Hunger-Immune-Metabolic/dp/B0H2R8HKS4 — and Kindle) and Barnes & Noble.
• She also publishes an in-depth health e-zine at wellth-e.com (WELLTH-E — "wealth" as in money plus wellness); she points listeners to issue #3

Bottom line: For an otherwise healthy, fit person chasing a modest amount of weight, Dr. Loh's take is stay away if you can — the muscle and immune-metabolic costs outweigh the benefit, and these drugs are best reserved for clear medical need, used with a real clinician and a defined exit strategy.

*Note: Educational, not medical advice. Dr. Loh stresses these decisions should be made with a clinician genuinely involved in your care.*

1. Ask "where's the receptor?" to tell a direct drug effect from a general weight-loss effect.
2. Metabolism and immunity are inseparable — every metabolic change is an immune change.
3. Insulin resistance is an adaptive response; acute is healthy, chronic is the problem.
4. The drug delivers GLP-1 alone and supraphysiologically — missing the natural hormone "family" and overriding your own system.
5. GLP-1 curbs appetite partly by inducing a low-grade "sickness" state via IL-6.
6. IL-6 isn't just "bad"; suppressing it long-term may drive muscle loss and impair repair.
7. Biggest risk for fit people: trading fat for lost muscle (obesity+diabetes → sarcopenia+diabetes).
8. ~75% regain most weight within a year of stopping, even while keeping good diet habits.
9. Beware catabolic states — surgery, illness, immobility — while on these drugs.
10. Skip no-follow-up, online platforms; pair any GLP-1 use with real lifestyle structure (meals, protein, hydration, sleep, lifting).

• Two years after her last appearance, Dr. Vyvyane Loh returns to tackle the drugs everyone's asking about — the GLP-1s (Ozempic, Wegovy, semaglutide). Joe comes in tempted, like a lot of listeners: not a hundred pounds to lose, just a stubborn ten and the promise that these drugs are also good for your heart, kidneys, liver, and longevity. Dr. Loh's job in this episode is to separate what's real from what's hype — and to explain what these drugs may be costing that the marketing never mentions.
• Her first tool for cutting through the noise is a simple question: "where is the GLP-1 receptor?" If a supposed benefit is happening in a tissue that has no GLP-1 receptor, it's probably just a general effect of losing weight (better sleep apnea, less inflammation) — not a direct, magical property of the drug. Much of the "good for everything" story, she argues, is really just "weight loss is good for people who were carrying excess fat."
• The conceptual heart of the episode is her core thesis: metabolism and the immune system are the same conversation. Any metabolic intervention is also an immune intervention, and vice versa. She reframes insulin resistance not as a villain but as a natural, adaptive response — during infection, inflammation, or pregnancy, the b...